TCW Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-46,020
| Closed | -$1.75M | – | 315 |
|
|
2018
Q4 | $1.75M | Buy |
46,020
+410
| +0.9% | +$15.6K | 0.02% | 226 |
|
|
2018
Q3 | $1.81M | Buy |
45,610
+6,660
| +17% | +$264K | 0.01% | 234 |
|
|
2018
Q2 | $1.37M | Buy |
38,950
+10,850
| +39% | +$381K | 0.01% | 248 |
|
|
2018
Q1 | $983K | Buy |
28,100
+1,850
| +7% | +$64.7K | 0.01% | 272 |
|
|
2017
Q4 | $911K | Hold |
26,250
| – | – | 0.01% | 281 |
|
|
2017
Q3 | $889K | Hold |
26,250
| – | – | 0.01% | 292 |
|
|
2017
Q2 | $895K | Hold |
26,250
| – | – | 0.01% | 292 |
|
|
2017
Q1 | $817K | Hold |
26,250
| – | – | 0.01% | 309 |
|
|
2016
Q4 | $717K | Hold |
26,250
| – | – | 0.01% | 566 |
|
|
2016
Q3 | $863K | Hold |
26,250
| – | – | 0.01% | 512 |
|
|
2016
Q2 | $792K | Hold |
26,250
| – | – | 0.01% | 535 |
|
|
2016
Q1 | $739K | Sell |
26,250
-850
| -3% | -$23.9K | 0.01% | 559 |
|
|
2015
Q4 | $920K | Hold |
27,100
| – | – | 0.01% | 513 |
|
|
2015
Q3 | $862K | Sell |
27,100
-8,600
| -24% | -$274K | 0.01% | 546 |
|
|
2015
Q2 | $1.14M | Hold |
35,700
| – | – | 0.01% | 501 |
|
|
2015
Q1 | $1.22M | Sell |
35,700
-2,800
| -7% | -$95.8K | 0.01% | 691 |
|
|
2014
Q4 | $1.36M | Buy |
38,500
+3,400
| +10% | +$120K | 0.01% | 669 |
|
|
2014
Q3 | $1.25M | Hold |
35,100
| – | – | 0.01% | 692 |
|
|
2014
Q2 | $1.3M | Hold |
35,100
| – | – | 0.01% | 692 |
|
|
2014
Q1 | $1.14M | Sell |
35,100
-35,300
| -50% | -$1.15M | ﹤0.01% | 706 |
|
|
2013
Q4 | $2.09M | Hold |
70,400
| – | – | 0.01% | 663 |
|
|
2013
Q3 | $1.83M | Hold |
70,400
| – | – | 0.01% | 673 |
|
|
2013
Q2 | $1.67M | Buy |
+70,400
| New | +$1.67M | 0.01% | 659 |
|